Le DSIP It acts as a modulator of circadian rhythms by normalizing sleep architecture
Multiple cell experiments have shown that IGF-1 LR3 can improve the tight junction structure by upregulating the expression of tight junction proteins such as occludin, ZO-1, claudin-1, etc
,
Learn more Peptide Therapy Skin, recovery, longevity and metabolic peptide protocols
PlexusDx recommends combining this clinical vetting with genetic insights: knowing your GLP1R and GIPR predispositions can support a richer conversation with your provider about why you may be a better candidate for semaglutide versus tirzepatide, or whether microdose protocols might suit your tolerability profile better
Jos Manuel Carrascosa ha participado como IP/SI y/o ponente invitado y/o advisor para Almirall, Janssen, Abbvie, UCB, Boehringer-Ingelheim, Lilly, Novartis, Amgen, BMS y Sandoz